Probiotics : Sources, Types and Health Benefits.

Intro -- PROBIOTICS -- PROBIOTICS -- CONTENTS -- PREFACE -- ROLE OF PROBIOTICS AND DIETARY FIBRE IN MAINTAINING HEALTHY GUT FLORA -- ABSTRACT -- INTRODUCTION -- CONCEPT OF FIBRE -- DEVELOPMENT AND EVOLUTION OF FIBRE DETERMINATION METHODS -- CLASSIFICATION OF DIETARY FIBRE -- RICE -- SOLUBLE AND INSOLUBLE FIBRE IN RICE -- PHYSIOLOGICAL AND METABOLIC EFFECTS OF DIETARY FIBRE ON HUMAN HEALTH -- Daily Intake of Dietary Fibre -- Fermentation of Dietary Fibre -- Why In-Vitro Fermentation? -- LIMITATIONS AND IMPORTANCE OF IN-VITRO FERMENTATION -- IN-VITRO FERMENTATION MODELS -- PRODUCTS FROM THE FERMENTATION OF DIETARY FIBRE -- SHORT CHAIN FATTY ACIDS AND THEIR IMPLICATIONS -- FACTORS INFLUENCING SCFA FORMATION DURING FERMENTATION -- CONCEPT OF PREBIOTIC, PROBIOTIC, AND SYMBIOTIC -- COLONIC FOOD AND PREBIOTICS -- CURRENT PROBIOTIC POSITION AND STATE OF THE ART -- Lactobacillus Species -- BIFIDOBACTERIUM SPECIES -- CONCEPT OF SYMBIOTIC -- STRATEGY FOR ACETATE, PROPIONATE AND BUTYRATE FORMATION BY BIFIDOBACTERIA AND LACTOBACILLUS SPECIES -- MICROBIAL ADHESION -- CONCLUSION -- REFERENCES -- PORCINE TOLL-LIKE RECEPTORS AND THEIR CROSSTALK WITH IMMUNOBIOTICS: IMPACT IN THE REGULATION OF GUT INFLAMMATORY IMMUNITY -- ABSTRACT -- INTRODUCTION -- THE INNATE IMMUNE SYSTEM IN THE GUT: ROLE OF TOLL-LIKE RECEPTORS IN INNATE IMMUNITY AND TOLERANCE -- IMMUNOREGULATORY EFFECT OF LACTIC ACID BACTERIA IN INTESTINAL INNATE IMMUNITY VIA PATTERN RECOGNITION RECEPTORS -- FUNCTIONAL EXPRESSION OF TLRS IN SWINE GUT-ASSOCIATED LYMPHOID TISSUES (GALT) -- CONSTRUCTION OF MOLECULAR IMMUNOASSAY SYSTEM FOR THE DISCOVERY OF NOVEL IMMUNOBIOTICS AND IMMUNOGENICS -- UTILIZATION OF PORCINE INTESTINAL EPITHELIAL CELLS FOR SELECTION AND STUDY OF IMMUNOBIOTICS -- Modulation of TLR4-Mediated Inflammatory Response in PIE Cells by Immunobiotics.

Modulation of TLR3-Mediated Anti-Viral Inflammatory Response in PIE Cells by Immunobiotics -- CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- LACTOBACILLUS PLANTARUM: FUNCTIONAL CHARACTERISTICS FOR PROBIOTIC APPLICATIONS -- ABSTRACT -- INTRODUCTION -- FUNCTIONAL PROPERTIES -- HEALTH BENEFITS AND THERAPEUTIC EFFECTS -- FOOD AND PHARMACEUTICAL APPLICATIONS -- CONCLUSION -- REFERENCES -- PROBIOTICS IN THE PREVENTION AND TREATMENT OF ELDERLY DISEASE -- ABSTRACT -- INTRODUCTION -- AGE-RELATED ALTERATIONS IN THE INTESTINAL MICROBIOTA -- AGE-RELATED ALTERATIONS IN COLONIC METABOLIC ACTIVITY -- PROBIOTICS IN THE PREVENTION AND TREATMENT OF ELDERLY DISEASE -- APPENDIX I. PUBLISHED LITERATURE FOCUSED ON THE USE OF PROBIOTICS IN ELDERLY DISEASE -- 1) Gut Microecology -- 2) Bowel Movement, Constipation, and Gut transit Time -- 3) Irritable Bowel Syndrome -- 4) Antibiotic-associated Diarrhea (AAD) -- 5) Bacterial Vaginosis (BV) -- 6) Immune Modulation -- 7) Common Cold, Influenza, and Common Infectious Diseases -- 8) Miscellaneous Health Targets -- CONCLUSION -- REFERENCES -- PROBIOTIC BACTERIA AND HUMAN HEALTH: THE CASE OF PROBIOTIC PECORINO CHEESE -- ABSTRACT -- PROBIOTIC BACTERIA AND HUMAN HEALTH -- Probiotics and Immune System -- Probiotics and Cancer -- Probiotics and Cholesterol -- Probiotics and Modulation of Intestinal Microflora -- Probiotics and Lactose Intolerance -- THE USE OF PROBIOTIC IN CHEESE -- PROBIOTIC OVINE CHEESE -- REFERENCES -- PROBIOTICS AGAINST ENTERIC INFECTIONS. MECHANISMS OF ACTION AND EXPERIMENTAL EVIDENCE -- ABSTRACT -- INTRODUCTION: PROBIOTICS IN THE BEGINNING -- BENEFICIAL EFFECTS ATTRIBUTED TO PROBIOTIC AND MECHANISMS OF ACTION -- DIFFERENT MODES OF ACTION OF PROBIOTICS AGAINST ENTEROPATHOGENS: EXPERIMENTAL EVIDENCE USING CELLULAR LINES OR ANIMAL MODELS.

1. Non Immune Mechanisms Induced by Probiotics. Improvement of the Gastrointestinal Barrier -- 1.1. Influence of Probiotics in the Composition and Activity of the Gut Microbiota -- 1.2. Probiotics Can Produce Antimicrobial Compounds and Induce the Synthesis and Secretion of Antimicrobial Peptides by Enterocytes and Paneth Cells -- 1.3. Probiotics Stimulate Mucus Secretion -- 1.4. Competition for Adhesion Sites -- 2. Probiotics Modulate the Immune System, Preventing or Attenuating Diverse Enteric Infectious Diseases. Evidence Obtained in our Laboratory -- PROBIOTICS CAN PREVENT OR ALLEVIATE ENTERIC INFECTIONS OF DIFFERENT ETIOLOGY IN HUMANS. EXPERIMENTAL EVIDENCE -- CONCLUSION -- REFERENCES -- PROBIOTICS: A NEW PARADIGM IN THE MANAGEMENT OF BACTERIAL VAGINOSIS -- ABSTRACT -- INTRODUCTION -- THE VAGINAL ECOSYSTEM -- WHAT IS BACTERIAL VAGINOSIS? -- EVOLUTION OF BACTERIAL VAGINOSIS -- CLINICAL ASPECTS OF BACTERIAL VAGINOSIS -- WHY PROBIOTICS? -- SELECTION OF PROBIOTIC STRAINS FOR BACTERIAL VAGINOSIS -- EFFICACY OF PROBIOTIC STRAINS FOR TREATMENT OF BACTERIAL VAGINOSIS: EVIDENCE FROM CLINICAL TRIALS -- Is there Enough Evidence? -- EFFICACY OF PROBIOTIC STRAINS FOR TREATMENT OF BACTERIAL VAGINOSIS: EVIDENCE FROM CLINICAL TRIALS -- Is there Enough Evidence? -- SUMMARY -- REFERENCES -- ANTIBIOTIC RESISTANCE AND PROBIOTICS: ROLES, MECHANISMS AND EVIDENCE* -- ABSTRACT -- INTRODUCTION -- ROLES OF PROBIOTICS IN PREVENTING AND TREATING ANTIBIOTIC RESISTANCE -- Prevalence of Probiotics in Preventing Antibiotics Resistance -- Prevalence of Probiotics in Treating Antibiotic-Resistant Infections and Reducing Pathogens with Antibiotic Resistance -- NON-ANTIBIOTIC RESISTANCE AS A CRITERION FOR PROBIOTICS -- Importance of Non-Antibiotic Resistance as a Criterion for Probiotics -- Legislation and Recommendation on Antibiotic Resistant Probiotics.

Translocation of Antibiotic-Resistant Probiotics -- MECHANISM OF ACQUIRING ANTIBIOTIC RESISTANCE IN PROBIOTICS -- Actions of Antibiotics and Antibiotic Resistance -- Types of Resistance -- Natural or Intrinsic Resistance -- Acquired Resistance -- Vertical Evolution - Spontaneous Mutation and Selection Process -- Horizontal Evolution - Gene Exchange -- IN VITRO AND IN VIVO EVIDENCE -- Emergence of Antibiotic Resistance among Starter Cultures and Probiotic Strains -- The Global Epidemiology of Antibiotic-Resistant Probiotic Strains -- DETECTION AND ELIMINATION OF ANTIBIOTIC RESISTANCE IN PROBIOTICS -- CONCLUSION -- ACKNOWLEDGMENT -- REFERENCES -- PROBIOTICS IN MATERNAL AND EARLY INFANT NUTRITION* -- ABSTRACT -- 1. INTRODUCTION -- 2. MICROBIOTA ACQUISITION AND SUCCESSION IN THE NEWBORN INTESTINE -- 3. INFLUENCE OF THE INTESTINAL MICROBIOTA IN HOST PHYSIOLOGY AND IMMUNITY DURING THE EARLY POSTNATAL PERIOD -- 3.1. Influence of the Intestinal Microbiota in Host Physiology and Metabolism -- 3.2. Influence of the Intestinal Microbiota in Host Immunity -- 4. INFLUENCE OF THE MOTHER'S DIET AND ENVIRONMENTAL EXPOSURES IN FETAL PROGRAMMING AND INFANT'S HEALTH -- 5. PROBIOTIC AND PREBIOTIC CONCEPTS AND APPLICATIONS -- 6. INFLUENCE OF MATERNAL AND OFFSPRING PROBIOTIC INTAKE IN ANIMALS -- 7. INFLUENCE OF MATERNAL AND INFANT PROBIOTIC INTAKE IN HUMANS -- 7.1. Influence of Maternal Probiotic Intake in the Intestinal Microbiota of the Infants -- 7.2. Influence of Maternal and Infant Probiotic Intake in Child Health -- CONCLUSIONS AND FURTHER PERSPECTIVES -- ACKNOWLEDGMENTS -- REFERENCES -- INDEX.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.